RadResQ develops dual-modified mesenchymal stem cells engineered with ECSOD and CXCR4 for radiation protection. Our proprietary genetic modification process creates "super-charged" stem cells within specialized culture systems. This approach enhances cellular antioxidant defenses while improving therapeutic targeting to radiation-damaged
RadResQ develops dual-modified mesenchymal stem cells engineered with ECSOD and CXCR4 for radiation protection. Our proprietary genetic modification process creates "super-charged" stem cells within specialized culture systems. This approach enhances cellular antioxidant defenses while improving therapeutic targeting to radiation-damaged tissues. Our AI agents optimize transfection efficiency and monitor expression levels for consistent therapeutic potency. Custom protocols ensure optimal cell viability and functionality through automated quality control workflows enabling immediate deployment for space missions and emergency response scenarios.
In our organ-on-chip validation system, engineered MSCs are tested within interconnected microfluidic tissue models that simulate human physiological responses to 0.5 Gy radiation exposure. This process evaluates therapeutic efficacy through real-time monitoring of oxidative stress markers, DNA damage indicators, and cellular recovery pat
In our organ-on-chip validation system, engineered MSCs are tested within interconnected microfluidic tissue models that simulate human physiological responses to 0.5 Gy radiation exposure. This process evaluates therapeutic efficacy through real-time monitoring of oxidative stress markers, DNA damage indicators, and cellular recovery patterns. Our AI systems manage complex multi-organ interactions while tracking biomarker responses across simulated bone marrow, liver, and gastrointestinal modules. Specialized agentic workflows orchestrate experimental parameters, data collection, and analysis to validate MSC protective effects before advancing to clinical applications.
For space deployment, RadResQ delivers validated engineered MSCs as prophylactic treatment for astronauts prior to mission launch, providing biological radiation shielding equivalent to physical armor without weight penalties. This prepared cellular therapeutic is administered via standardized protocols optimized for crew protection durin
For space deployment, RadResQ delivers validated engineered MSCs as prophylactic treatment for astronauts prior to mission launch, providing biological radiation shielding equivalent to physical armor without weight penalties. This prepared cellular therapeutic is administered via standardized protocols optimized for crew protection during long-duration Mars missions. Custom AI agents coordinate pre-mission dosing, monitor therapeutic persistence, and track radiation protection efficacy throughout mission phases. Specialized partnerships with space agencies enable integration into astronaut medical protocols, ensuring continuous biological countermeasure coverage for humanity's greatest exploration challenges.
"Any pattern found in nature can be efficiently modeled through the power of artificial intelligence; welcome to the era of multi-agentic discovery." - Dr. James Utley, PhD
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.